Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5841

1.

INU-LA-PEG-FA coated SPIONs loading doxorubicin for solid tumour chemotherapy.

Licciardi M, Scialabba C, Puleio R, Cassata G, Cicero L, Cavallaro G, Giammona G.

Int J Pharm. 2018 Dec 6. pii: S0378-5173(18)30897-4. doi: 10.1016/j.ijpharm.2018.11.069. [Epub ahead of print]

PMID:
30529663
2.

Bacterial folate biosynthesis and colorectal cancer risk: more than just a gut feeling.

Kok DE, Steegenga WT, Smid EJ, Zoetendal EG, Ulrich CM, Kampman E.

Crit Rev Food Sci Nutr. 2018 Dec 3:1-13. doi: 10.1080/10408398.2018.1522499. [Epub ahead of print]

PMID:
30501511
3.

Chemotherapy-induced liver injury in metastatic colorectal cancer: about 48 cases.

Limaiem F, Bouraoui S.

Pan Afr Med J. 2018 Jul 5;30:198. doi: 10.11604/pamj.2018.30.198.15548. eCollection 2018.

4.

Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.

Bendardaf R, Sharif-Askari FS, Sharif-Askari NS, Syrjänen K, Pyrhönen S.

Anticancer Res. 2018 Nov;38(11):6399-6404. doi: 10.21873/anticanres.13000.

PMID:
30396964
5.

A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes.

Handali S, Moghimipour E, Rezaei M, Ramezani Z, Kouchak M, Amini M, Angali KA, Saremy S, Dorkoosh FA.

Biomed Pharmacother. 2018 Dec;108:1259-1273. doi: 10.1016/j.biopha.2018.09.128. Epub 2018 Oct 3.

6.

Folate/Vitamin B12 Supplementation Combats Oxidative Stress-Associated Carcinogenesis in a Rat Model of Colon Cancer.

Padmanabhan S, Waly MI, Taranikanti V, Guizani N, Ali A, Rahman MS, Al-Attabi Z, Al-Malky RN, Al-Maskari SNM, Al-Ruqaishi BRS, Dong J, Deth RC.

Nutr Cancer. 2018 Oct 29:1-11. doi: 10.1080/01635581.2018.1513047. [Epub ahead of print]

PMID:
30372163
7.

Graphene Oxide⁻PEG⁻Protocatechuic Acid Nanocomposite Formulation with Improved Anticancer Properties.

Saifullah B, Buskaran K, Shaikh RB, Barahuie F, Fakurazi S, Mohd Moklas MA, Hussein MZ.

Nanomaterials (Basel). 2018 Oct 11;8(10). pii: E820. doi: 10.3390/nano8100820.

8.

[Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer].

Cai Y, Deng R, Hu H, Zhang J, Ling J, Wu Z, Yang L, Li J, Deng Y.

Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1045-1050. Chinese.

PMID:
30269326
9.

A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).

Kusano M, Aoyama T, Okabayashi K, Hirata K, Tsuji Y, Nakamori S, Asahara T, Ohashi Y, Yoshikawa T, Sakamoto J, Oba K, Saji S.

J Cancer Res Ther. 2018 Sep;14(Supplement):S761-S766. doi: 10.4103/0973-1482.179188.

10.

The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More?

Lee JJ, Chu E.

Oncology (Williston Park). 2018 Sep 15;32(9):437-42, 444. Review.

11.

Alcohol Intake and Colorectal Cancer Risk in the Multiethnic Cohort Study.

Park SY, Wilkens LR, Setiawan VW, Monroe KR, Haiman CA, Le Marchand L.

Am J Epidemiol. 2018 Sep 15. doi: 10.1093/aje/kwy208. [Epub ahead of print]

PMID:
30239578
12.

[Primary Small Bowel Tumor with Simultaneous Lung Metastases from Rectal Cancer - A Case Report].

Shinohara S, Hyodo M, Ota G, Hayashi H, Inoue Y, Sato H, Tsukahara M, Okada M, Lefor AK, Yasuda Y.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1377-1379. Japanese.

PMID:
30237386
13.

Oxaliplatin treatment and peripheral nerve damage in cancer patients: A Polish cohort study.

Banach M, Zygulska AL, Krzemieniecki K.

J Cancer Res Ther. 2018 Jul-Sep;14(5):1010-1013. doi: 10.4103/jcrt.JCRT_971_16.

14.

Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial.

Marco MR, Zhou L, Patil S, Marcet JE, Varma MG, Oommen S, Cataldo PA, Hunt SR, Kumar A, Herzig DO, Fichera A, Polite BN, Hyman NH, Ternent CA, Stamos MJ, Pigazzi A, Dietz D, Yakunina Y, Pelossof R, Garcia-Aguilar J; Timing of Rectal Cancer Response to Chemoradiation Consortium.

Dis Colon Rectum. 2018 Oct;61(10):1146-1155. doi: 10.1097/DCR.0000000000001207.

PMID:
30192323
15.

[Azacitidine for Therapy-Related Myelodysplastic Syndrome Following Oxaliplatin (L-OHP)Therapy for Metastatic Rectal Cancer].

Matsui T, Sakamoto N, Doi A, Fujii T, Ohno N, Sahara N, Irie S.

Gan To Kagaku Ryoho. 2018 Aug;45(8):1201-1203. Japanese.

PMID:
30158420
16.

Pharmacological and dietary factors in prevention of colorectal cancer.

Waluga M, Zorniak M, Fichna J, Kukla M, Hartleb M.

J Physiol Pharmacol. 2018 Jun;69(3). doi: 10.26402/jpp.2018.3.02. Epub 2018 Aug 22. Review.

17.

Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.

Hubert C, Lucidi V, Weerts J, Dili A, Demetter P, Massart B, Komuta M, Navez J, Reding R, Gigot JF, Sempoux C.

Eur J Surg Oncol. 2018 Oct;44(10):1532-1538. doi: 10.1016/j.ejso.2018.07.050. Epub 2018 Jul 27.

PMID:
30093084
18.

Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis.

Shui L, Wu YS, Lin H, Shui P, Sun Q, Chen X.

Cell Physiol Biochem. 2018;48(5):1870-1881. doi: 10.1159/000492508. Epub 2018 Aug 9.

19.

Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes.

Sohail MF, Sarwar HS, Javed I, Nadhman A, Hussain SZ, Saeed H, Raza A, Irfan Bukhari N, Hussain I, Shahnaz G.

Toxicol Res (Camb). 2017 Jul 24;6(6):814-821. doi: 10.1039/c7tx00146k. eCollection 2017 Nov 1.

20.

Safety and antitumor activity of arsenic trioxide plus infusional 5-fluorouracil, leucovorin, and irinotecan as second-line chemotherapy for refractory metastatic colorectal cancer: A pilot study from South India.

Lakshmaiah KC, Chaudhuri T, Babu GK, Lokanatha D, Jacob LA, Suresh Babu MC, Rudresha AH, Lokesh KN, Rajeev LK.

Indian J Cancer. 2017 Oct-Dec;54(4):631-633. doi: 10.4103/ijc.IJC_374_17.

Supplemental Content

Loading ...
Support Center